Search

everythinglearnresearchcommunity

for

Search:↓

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Sorafenib can cause a temporary skin condition that goes away after stopping the drug.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Most patients with hard-to-treat high blood pressure can be managed effectively with various treatments, but no single treatment is perfect.

Bortezomib chemotherapy can cause temporary skin rashes.

Activated ras can protect kidney cells from a certain substance that causes cell death.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Forsythiaside A helps reduce brain damage from lack of blood flow by activating certain protective pathways.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Betulinic acid can help treat hepatitis C by stopping virus replication.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Baricitinib works better than methotrexate for severe alopecia areata.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.